The purpose of this memo is to notify childcare operators/Head Start directors and Pre-K classrooms of the 2025 annual immunization reporting requirements.
Press Releases
This email is to inform you that the North Carolina Immunization Program (NCIP) has opened applications for birthing hospitals interested in participating in the replacement model for birth dose Hepatitis B and RSV.
The purpose of this email is to inform VFC-enrolled providers that the RSV monoclonal antibody product clesrovimab (trade name ENFLONSIA™ manufactured by Merck) is now available for ordering. VFC doses will begin shipping after October 2, 2025.
The purpose of this memo is to remind local health department (LHD) staff about the upcoming 2025 Annual Immunization Assessment. This assessment will review NCIR records of children, 24 through 35 months old, who are labeled "active" in NCIR under the LHD site, as well as all children that live in the county.
All North Carolina public, private, and religious schools are required annually to report on the immunization status of all students in kindergarten, seventh grade, and twelfth grade (G.S. 130A-155(c) PDF).
All North Carolina public schools, including public charter schools are required annually to report on the status of Health Assessments for those students who are enrolling for the first time in a North Carolina public or public charter school (§ 130A-441(c) PDF, and the immunization status of all students in kindergarten, seventh, and twelfth grade (G.S. 130A-155(c) PDF).
This email is to inform you that the North Carolina Immunization Program (NCIP) has doses of 317 VFA ABRYSVO® vaccine available for order for non-Medicaid, uninsured pregnant women between 32 to 36 weeks of gestation during September through January, who are receiving services at the local health department.
Dear Colleagues,The North Carolina Immunization Program (NCIP) is pleased to announce the presentation of the Samuel L. Katz, M.D. Excellence in Immunization Award during the 2026 NC DHHS Vaccines for Children Conference, scheduled March 4 – 6, 2026, at the Koury Conference Center in Greensboro, NC. This award recognizes outstanding individuals or organizations that have implemented innovative strategies to enhance immunization coverage among children, adolescents, and adults.